Institute of Biomedical Research of Barcelona - Spanish National Research Council
The Institute of Biomedical Research of Barcelona (IIBB) is a centre of the Spanish National Research Council (CSIC) currently structured in four departments: the Department of Ischemia and Inflammation, the Department of Cerebral Ischemia and Neurodegeneration, the Department of Cell Death and Proliferation, and the Department of Neuropharmachology, as well as a Proteomics Unit. The institute is located on the 6th and 7th floors of the outpatient building of Hospital Clínic de Barcelona (C/ Rosselló 161, 08036 Barcelona), with the exception of the Proteomics Unit, which is located at the Autonomous University of Barcelona (Faculty of Medicine, Department of Biochemistry - Building M - UAB, Campus of Bellatera, Cerdanyola del Vallès).
The staff of the IIBB (see directory) is made up of 110 scientific personnel (29 staff and 81 contracted scientists), pre- and postdoctoral scholars, 42 support staff and 20 administration and services personnel.
The IIBB is active in the field of basic biomedical research. The research conducted at the centre is of a clear traslational character, intended to meet the needs of society with regard to high-incidence diseases and therapeutic and surgical treatments with significant social repercussions in the areas of neoropharmacology, neurobiology, experimental pathology and proteomics. Within these disciplines, subjects as different as neural proliferation, neuroprotection, neurotoxicity, inflammation, apoptosis, ischemia-reperfusion and homeostasis are approached.
The institute has already made significant contributions in the improvement of therapeutic and surgical approaches to psychiatric and neurological diseases (depression, schizophrenia, ictus, Alzheimer's disease, neurotoxical processes, etc.), and pathologies in which inflammatory processes and cell death play an essential role (primary failure in organ transplantation, hepathopathies, pancreatitis and pulmonary failure).
The IIBB is well equipped to perform its many functions, with facilities for tissue cultures, histology, microscopy, imaging and chemical analyses (chromatography, mass spectrometry). During the last five years, the scientific staff of the Institute of Biomedical Research of Barcelona has been granted a total of €7,000,000 for research projects from public funding entities such as the from CICYT, FIS, EU, Instituto de Salud Carlos III, RETICS, NETWORKS, CIBERS, the Government of Catalonia and through agreements for research projects funded by the private sector (fundamentally pharmaceutical companies).
From 2003 to 2007, the institute's research groups published a total of 291 scientific articles with a combined impact factor in the Science Citation Index of 1,251.041 points – a an average of 4.624 IF points/publication. This CSIC institute is part of the August Pí and Sunyer Biomedical Research Institute (IDIBAPS), created by an agreement between the Government of Catalonia, the University of Barcelona, Hospital Clínic and the CSIC to promote high quality research in biomedicine in Catalonia.
The IIBB is also an important centre for third cycle training, where doctoral theses are drafted in the fields of neurosciences and biomedicine. Several members of the IIBB are teachers and tutors in doctoral programs offered at the University of Barcelona and the Autonomous University of Barcelona.